Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunobiologic consequences of assist devices.

Silviu Itescu1, Michael Schuster, Elizabeth Burke

  • 1College of Physicians and Surgeons of Columbia University, 622 West 168th Street, New York, NY 10032, USA. si5@columbia.edu

Cardiology Clinics
|June 7, 2003
PubMed
Summary

Host-device interactions impair immune responses in Ventricular Assist Device (VAD) recipients. This leads to weakened cellular immunity, increased infection risk, and heightened transplant rejection risk due to immune dysregulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic Review of Chimeric Antigen Receptor T-cell Therapy in Autoimmune Diseases.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same author

A.Kocher Technique: A Simplified Universally Applicable Approach for Aortic Root Enlargement.

Innovations (Philadelphia, Pa.)·2026
Same author

CT-Based Annular Dimensions in Transcatheter Mitral Valve Replacement: A Multicenter Registry Study.

The Annals of thoracic surgery·2026
Same author

The 10 Commandments for Oral Anticoagulation After Tissue Valve Replacement.

Innovations (Philadelphia, Pa.)·2026
Same author

Transcatheter Versus Minimally Invasive Surgical Aortic Valve Replacement With Rapid-Deployment Valves: A Propensity-Matched Analysis.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Automated Suture Securing Technology in Mitral Valve Surgery: A Strategy to Reduce Prosthetic Dehiscence?

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026

Area of Science:

  • Immunology
  • Biomedical Engineering
  • Transplantation Science

Background:

  • Host-device interactions with medical implants can trigger aberrant immune responses.
  • Ventricular Assist Devices (VADs) are critical for end-stage heart failure but can induce immune system alterations.
  • Understanding these immune changes is crucial for improving VAD therapy and transplant outcomes.

Purpose of the Study:

  • To elucidate the specific immune dysregulations occurring in VAD recipients.
  • To identify the mechanisms driving impaired cellular immunity and increased infection risk.
  • To investigate the factors contributing to allosensitization and potential transplant rejection.

Main Methods:

  • Analysis of monocyte and T-cell activation markers in VAD recipients.

Related Experiment Videos

  • Assessment of CD4 T-cell subsets (Th1 and Th2) and their functions.
  • Evaluation of B-cell responses, immunoglobulin synthesis, and CD40 ligand-CD40 interactions.
  • Correlation of immune profiles with clinical outcomes, including infection and allosensitization.

    • Main Results:

    • VAD implantation leads to selective loss of Th1 cytokine-producing CD4 T cells via activation-induced cell death.
    • Unopposed activation of Th2 cytokine-producing CD4 T cells results in B-cell hyperreactivity and dysregulated immunoglobulin production.
    • Heightened CD40 ligand-CD40 interactions exacerbate immune dysregulation.
    • VAD recipients exhibit progressive defects in cellular immunity, increasing infection susceptibility.
    • Increased likelihood of allosensitization in VAD recipients, posing a risk to subsequent transplantation.

    Conclusions:

    • VAD-induced immune alterations significantly compromise cellular immunity and increase infection risk.
    • Immune dysregulation, particularly Th2 skewing and B-cell hyperreactivity, contributes to allosensitization in VAD patients.
    • Addressing these immune defects is critical for improving VAD patient management and enhancing the success of future organ transplantation.